新添“白酒+食品飲料”標籤 大豪科技(603025.SH)連續第三日漲停
格隆匯12月9日丨停牌前一個交易日率先漲停的大豪科技(603025.SH)昨日復牌一字漲停,今早再度一字漲停,報價10.52元,為連續第三日漲停,目前漲停封單逼近500萬手,暫成交169萬元,最新總市值97億元。12月7日晚間大豪科技正式公告重組預案,通過發行股份及支付現金購買資產和募集配套資金兩種方式,公司將直接和間接持有紅星股份100%股權。紅星股份主營業務為白酒的研發、生產和銷售,其最為大眾熟知的產品為“紅星二鍋頭”。如本次重大資產重組順利實施,大豪科技除原有業務外,業務範圍將擴充至酒類、食品飲料等大消費領域,及應用於集成電路封裝、光電功能等新材料領域。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.